drugset
drugset / Trial / NCT01149096

Collection of Bone Marrow From Donors Treated With or Without Filgrastim

NCT01149096 ↗

Phase 3 Completed 13 enrolled Children's Oncology Group National Cancer Institute (NCI) · collab
RandomizedParallel-groupOpen-labelSupportive care

Summary

This randomized clinical trial is studying the side effects of collection of bone marrow from donors treated with or without filgrastim. Giving colony-stimulating factors, such as filgrastim (G-CSF), to donors helps the stem cells move from the bone marrow to the blood so they can be collected and stored.

Timeline

Start
2010-06-14
Primary completion
2011-12-14
Completion
2016-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject filgrastim Protein / enzyme biologic — Subcutaneous

Indications

No indication recorded.